REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N4 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N4 OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Apteka N4 OOO is based in Russia, with the head office in Moscow Oblast. It operates in the Pharmacies and Drug Stores industry. The company was established on March 23, 2004. The total number of employees is currently 13 (2022). In 2023, the company reported a net sales revenue drop of 7.53%. Its’ total assets recorded a growth of 8.64%. The net profit margin of Apteka N4 OOO decreased by 1.82% in 2023.

Headquarters
Sovetskaya, 1A, Pomeshtenie Hii
Moscow Oblast; Moscow Oblast; Postal Code: 141033

Contact Details: Purchase the Apteka N4 OOO report to view the information.

Basic Information
Total Employees:
Purchase the Apteka N4 OOO report to view the information.
Outstanding Shares:
Purchase the Apteka N4 OOO report to view the information.
Registered Capital:
Purchase the Apteka N4 OOO report to view the information.
Incorporation Date:
March 23, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka N4 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-7.53%
Total operating revenue
-7.53%
Operating profit (EBIT)
-50.41%
Net Profit (Loss) for the Period
-76.92%
Total assets
8.64%
Total equity
-29.82%
Operating Profit Margin (ROS)
-1.48%
Net Profit Margin
-1.82%
Return on Equity (ROE)
-45.49%
Quick Ratio
0.1%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?